BOSSI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 9896
EU - Europa 2407
AS - Asia 967
AF - Africa 17
OC - Oceania 17
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13320
Nazione #
US - Stati Uniti d'America 9863
CN - Cina 859
UA - Ucraina 837
IE - Irlanda 374
PL - Polonia 337
DE - Germania 308
IT - Italia 286
GB - Regno Unito 97
SE - Svezia 86
VN - Vietnam 59
CA - Canada 32
FR - Francia 26
AU - Australia 16
BE - Belgio 16
FI - Finlandia 15
IN - India 11
EG - Egitto 10
TR - Turchia 10
JP - Giappone 6
BR - Brasile 4
CH - Svizzera 4
EU - Europa 4
HK - Hong Kong 4
AR - Argentina 3
IR - Iran 3
MK - Macedonia 3
NL - Olanda 3
RO - Romania 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
ES - Italia 2
HR - Croazia 2
ID - Indonesia 2
KR - Corea 2
MA - Marocco 2
PK - Pakistan 2
RU - Federazione Russa 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
CL - Cile 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 13320
Città #
Fairfield 2226
Woodbridge 896
Jacksonville 844
Seattle 827
Ashburn 815
Houston 767
Cambridge 694
Wilmington 666
Princeton 634
Chandler 416
Warsaw 337
Dublin 332
Ann Arbor 282
Beijing 187
Des Moines 157
Nanjing 156
San Diego 149
Brescia 100
Shenyang 69
Changsha 58
Dong Ket 58
Hebei 52
Jinan 52
Nanchang 52
London 50
Jiaxing 49
Tianjin 46
Menlo Park 43
Ningbo 26
Rome 24
Norwalk 22
Toronto 20
Taizhou 18
Haikou 16
Hangzhou 16
San Francisco 16
Brussels 15
Dearborn 13
Hanover 13
Rende 13
Guangzhou 11
Cairo 10
Helsinki 10
Lanzhou 10
Milan 10
Canberra 9
Zhengzhou 9
Frankfurt am Main 8
Brooklyn 7
Cazzago San Martino 7
Verona 7
Fuzhou 6
Melbourne 6
Taiyuan 6
Augusta 5
Lancaster 5
Leawood 5
Arezzo 4
Bonn 4
Paris 4
Redwood City 4
Tokyo 4
Amsterdam 3
Berlin 3
Central 3
Chicago 3
Kocaeli 3
Kunming 3
Los Angeles 3
Markham 3
Nagold 3
New York 3
Phoenix 3
Venezia 3
Victoria 3
Villa Di Tirano 3
Voghera 3
Ardabil 2
Barcelona 2
Bari 2
Bucharest 2
Calcinate 2
Canton 2
Caserta 2
Cinto Caomaggiore 2
Cleveland 2
Cologno Monzese 2
Cordoba 2
Feroleto Della Chiesa 2
Fosses 2
Gauteng 2
Gunzenhausen 2
Hyderabad 2
Islamabad 2
Islington 2
Isola Della Scala 2
Ivancice 2
Lugano 2
Mountain View 2
Rho 2
Totale 11468
Nome #
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 155
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 146
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 142
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 138
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 125
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 119
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 114
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 108
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 97
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 96
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 95
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 94
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 94
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 91
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 90
Investigational drugs for head and neck cancer 87
Hope in cancer patients: the relational domain as a crucial factor 83
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 83
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 80
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 79
The Case Volume Issue in Head and Neck Oncology 78
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 78
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 76
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 76
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 76
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 75
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 75
The role of systemic therapy in the management of sinonasal cancer: A critical review 75
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 74
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 74
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 74
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 74
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 74
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 74
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 74
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 73
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 73
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 73
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 72
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 71
Multikinase inhibitors in thyroid cancer 71
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 71
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 70
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 70
TP53 mutations in head and neck cancer 70
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 70
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 69
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 69
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 69
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 69
Comments on "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure" by Chan and Coll 68
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 68
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 68
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 68
Pain related to cancer treatments and diagnostic procedures: a no man's land? 68
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 67
Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs) 67
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 67
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 66
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 66
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options 66
Emerging tyrosine kinase inhibitors for head and neck cancer 66
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 65
Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma 65
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 65
Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients 65
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 64
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 64
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 64
New insights in chemotherapy 64
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 64
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 64
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 64
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting 63
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 63
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma 63
Global cancer control: responding to the growing burden, rising costs and inequalities in access 63
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 63
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review 62
Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer 62
Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making 62
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 62
Comprehensive meta-analysis of publicly available microarray data in head and neck cancer 62
Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile 62
How Many Therapeutic Options Are There for Recurrent or Metastatic Salivary Duct Carcinoma? 62
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 62
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 62
Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse 62
Detecting characteristics of nodal invasion in advanced squamocellular oral cavity cancer through a gene expression profile on primary tumor 61
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis 61
Cisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience 61
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 61
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 60
Comment on "Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis", by Rades et coll 60
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base' 60
Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents 60
Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial 60
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 59
Totale 7485
Categoria #
all - tutte 53238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53238

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181 0000 00 00 0001
2018/2019927 0000 70 36 014548349
2019/20203642 471116142434 236386 485392 30138320690
2020/20215180 64473246996 298726 152517 344719283362
2021/20222332 11625255283 109212 76201 119195201513
2022/20231512 3588946113 92463 12103 148304612
Totale 13708